Bal Pharma has received upgrade in credit ratings from ICRA as under -
Long term fund based facilities - ICRA BB reaffirmed; Outlook revised to Stable from Negative.
Short term fund non fund based facilities - ICRA A4 reaffirmed
Long term - term loan - ICRA BB; Outlook revised to Stable from Negative.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
